.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Daiichi Sankyo
Cantor Fitzgerald
Covington
QuintilesIMS
UBS
Deloitte
Federal Trade Commission
Merck
Chinese Patent Office

Generated: June 24, 2017

DrugPatentWatch Database Preview

CLOMIPHENE CITRATE Drug Profile

« Back to Dashboard

Which patents cover Clomiphene Citrate, and when can generic versions of Clomiphene Citrate launch?

Clomiphene Citrate is a drug marketed by Par Pharm and is included in one NDA.

The generic ingredient in CLOMIPHENE CITRATE is clomiphene citrate. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the clomiphene citrate profile page.

Summary for Tradename: CLOMIPHENE CITRATE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Bulk Api Vendors: see list73
Clinical Trials: see list528
Patent Applications: see list442
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CLOMIPHENE CITRATE at DailyMed

Pharmacology for Tradename: CLOMIPHENE CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
CLOMIPHENE CITRATE
clomiphene citrate
TABLET;ORAL075528-001Aug 30, 1999ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Julphar
QuintilesIMS
Healthtrust
Johnson and Johnson
Cerilliant
Argus Health
Teva
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot